JP2004525111A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525111A5
JP2004525111A5 JP2002565606A JP2002565606A JP2004525111A5 JP 2004525111 A5 JP2004525111 A5 JP 2004525111A5 JP 2002565606 A JP2002565606 A JP 2002565606A JP 2002565606 A JP2002565606 A JP 2002565606A JP 2004525111 A5 JP2004525111 A5 JP 2004525111A5
Authority
JP
Japan
Prior art keywords
depsipeptide
animal
formula
crystalline form
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002565606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525111A (ja
Filing date
Publication date
Priority claimed from DE10104362A external-priority patent/DE10104362A1/de
Application filed filed Critical
Publication of JP2004525111A publication Critical patent/JP2004525111A/ja
Publication of JP2004525111A5 publication Critical patent/JP2004525111A5/ja
Pending legal-status Critical Current

Links

JP2002565606A 2001-02-01 2002-01-21 改良された強度を有する環式デプシペプチドの結晶変態 Pending JP2004525111A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104362A DE10104362A1 (de) 2001-02-01 2001-02-01 Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
PCT/EP2002/000541 WO2002066048A1 (de) 2001-02-01 2002-01-21 Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit

Publications (2)

Publication Number Publication Date
JP2004525111A JP2004525111A (ja) 2004-08-19
JP2004525111A5 true JP2004525111A5 (enExample) 2005-12-22

Family

ID=7672376

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002565606A Pending JP2004525111A (ja) 2001-02-01 2002-01-21 改良された強度を有する環式デプシペプチドの結晶変態

Country Status (27)

Country Link
US (1) US20040115483A1 (enExample)
EP (1) EP1357932B1 (enExample)
JP (1) JP2004525111A (enExample)
KR (2) KR20030081378A (enExample)
CN (1) CN1278735C (enExample)
AT (1) ATE284703T1 (enExample)
AU (1) AU2002226415B2 (enExample)
BR (1) BRPI0206841B8 (enExample)
CA (1) CA2436832C (enExample)
CR (1) CR7039A (enExample)
CZ (1) CZ299564B6 (enExample)
DE (2) DE10104362A1 (enExample)
EE (1) EE05490B1 (enExample)
ES (1) ES2233805T3 (enExample)
HR (1) HRP20030635A2 (enExample)
HU (1) HU229229B1 (enExample)
IL (2) IL157026A0 (enExample)
MX (1) MXPA03006866A (enExample)
NO (1) NO331289B1 (enExample)
NZ (1) NZ527230A (enExample)
PL (1) PL213106B1 (enExample)
PT (1) PT1357932E (enExample)
RU (1) RU2300390C2 (enExample)
SK (1) SK286280B6 (enExample)
UA (1) UA74623C2 (enExample)
WO (1) WO2002066048A1 (enExample)
ZA (1) ZA200305864B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080003546A1 (en) * 2006-06-29 2008-01-03 Dunbar Kimberly L Animated digital charted yarncraft instruction
RS62130B1 (sr) 2015-05-20 2021-08-31 Boehringer Ingelheim Animal Health Usa Inc Antihelmintička depsipeptidna jedinjenja
EP3397638B1 (en) 2015-12-28 2023-08-23 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
BR112019009977A2 (pt) 2016-11-16 2019-08-27 Boehringer Ingelheim Animal Health Usa Inc compostos depsipeptídicos anti-helmínticos
CN114262303A (zh) * 2022-01-04 2022-04-01 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型ii及其制备方法
CN114195732A (zh) * 2022-01-04 2022-03-18 丽珠集团福州福兴医药有限公司 一种艾默德斯的单晶型iii及其制备方法
CN115010680A (zh) * 2022-07-13 2022-09-06 丽珠集团福州福兴医药有限公司 单晶型i的艾默德斯及其制备方法
CN114989110A (zh) * 2022-07-13 2022-09-02 丽珠集团福州福兴医药有限公司 单晶型ⅳ的艾默德斯及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2096907A (en) * 1981-04-22 1982-10-27 Exxon Research Engineering Co Distillation column with steam stripping
DK0634408T3 (da) * 1992-03-17 2002-04-22 Fujisawa Pharmaceutical Co Depsipeptidderivater, fremstilling og anvendelse deraf
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
EP0872481B1 (en) * 1995-06-30 2009-03-18 Astellas Pharma Inc. Depsipeptide derivative, process for production thereof, and novel intermediate therefor
DE69634961T2 (de) * 1995-09-22 2006-04-20 Bayer Ag Neue zyklische depsipeptid pf1022 derivate
KR100551651B1 (ko) * 1997-11-10 2006-02-13 아스텔라스세이야쿠 가부시키가이샤 뎁시펩티드 유도체의 신규 결정 및 그의 제조 방법
DE10008128A1 (de) * 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
DE10031044A1 (de) * 2000-06-26 2002-01-03 Bayer Ag Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere

Similar Documents

Publication Publication Date Title
EP1862458A3 (en) Therapeutic agents useful for treating pain
JP2005518413A5 (enExample)
JP2006526031A5 (enExample)
JP2004533444A5 (enExample)
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
EP2260875A3 (en) Folate-receptor targeted imaging agents
RU2012123372A (ru) Гетероциклические модуляторы транспортеров атф-связывающей кассеты
JP2009545527A5 (enExample)
JP2007522220A5 (enExample)
JP2009017881A5 (enExample)
EP1797878A3 (en) Benzothiazole derivatives
JP2005053931A5 (enExample)
EP1576986A3 (en) Sustained-release tramadol formulations with 24-hour clinical efficacy
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
AR045317A1 (es) Forma cristalina de agonista dl receptor adrenergico b2
EP2308828A3 (en) CaSR antagonist
JP2005536503A5 (enExample)
RU2002100058A (ru) Кристаллические производные 1-метилкарбапенема
EA200401515A1 (ru) Новые фармацевтические композиции, содержащие флибансерин в полиморфной модификации а
JP2004502684A5 (enExample)
JP2010539091A5 (enExample)
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
JP2012511558A5 (enExample)
JP2008546809A5 (enExample)
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина